Filing Summary
Registrant: Agrify Corporation, although the request metadata identifies RYTHM, Inc. The filing is a Form 8-K reporting events dated January 27, 2021; it was signed February 2, 2021.
Business Context and Reporting Period
Agrify entered into an underwriting agreement with Maxim Group LLC in connection with its initial public offering. The company’s common stock traded under ticker AGFY on the Nasdaq Capital Market. Agrify identified itself as an emerging growth company.
Key Financial and Capital Markets Metrics
- Initial public offering: 5,400,000 shares of common stock.
- Offering price: $10.00 per share, before underwriting discounts and commissions.
- Underwriters received a 45-day option to purchase up to 810,000 additional shares to cover over-allotments.
- Estimated net proceeds: approximately $49.4 million after underwriting commissions and offering expenses, assuming no exercise of the over-allotment option.
- The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity balances for a comparable reporting period.
Material Changes and Use of Proceeds
The offering was priced on January 27, 2021 and closed on February 1, 2021. Agrify stated that it intends to use the proceeds for research and development of future products and software, sales and marketing, additional personnel, an equipment financing plan providing limited credit to customers, working capital, and other general corporate purposes.
Outlook, Risks, and Unusual Items
The filing contains forward-looking statements regarding the intended use of offering proceeds and other matters. Agrify noted that these statements involve risks and uncertainties and referred investors to risk disclosures in its other SEC filings. No specific operating guidance or financial forecast was provided.
Important Facts to Verify
- Confirm the issuer identity, because the supplied metadata names RYTHM, Inc., while the filing identifies Agrify Corporation.
- Verify whether the 810,000-share over-allotment option was exercised and the resulting total shares issued.
- Confirm final offering expenses and net proceeds in subsequent filings.
- Assess the company’s subsequent allocation of proceeds against the stated purposes.
- Review the registration statement, final prospectus, underwriting agreement, and related risk factors.